BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 3288467)

  • 41. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of nifedipine in treatment of hypertension.
    Murphy MB; Scriven AJ; Dollery CT
    Br Med J (Clin Res Ed); 1983 Jul; 287(6387):257-9. PubMed ID: 6409272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
    Pivac N; Dobovisek J; Bagatin J; Gros Furek V; Rumboldt Z; Janezić A; Kveder R; Sjerobabski V; Simunić M; Sardelić S
    Lijec Vjesn; 1993; 115(11-12):356-9. PubMed ID: 8176999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
    Leonetti G; Pasotti C; Capra A
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amlodipine versus atenolol in essential hypertension.
    Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG
    Am J Cardiol; 1994 Jan; 73(3):50A-54A. PubMed ID: 8310977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atenolol versus the fixed combination of atenolol and nifedipine in stable angina pectoris.
    Foale RA
    Eur Heart J; 1993 Oct; 14(10):1369-74. PubMed ID: 8262084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Captopril or atenolol in essential hypertension.
    Andrén L; Svensson A; Hansson L
    Acta Med Scand Suppl; 1983; 677():115-8. PubMed ID: 6367371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system.
    Testa MA; Hollenberg NK; Anderson RB; Williams GH
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):363-73. PubMed ID: 2059396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
    Myburgh DP; Gordon NF
    Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the anti-anginal efficacy of nicardipine and nifedipine in patients receiving atenolol: a randomized, double-blind, crossover study.
    Douard H; Mora B; Broustet JP
    Int J Cardiol; 1989 Mar; 22(3):357-63. PubMed ID: 2651328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia.
    Hill JA; Gonzalez JI; Kolb R; Pepine CJ
    Am J Cardiol; 1991 Apr; 67(8):671-5. PubMed ID: 2006616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
    Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atenolol and chlorthalidone in combination for hypertension.
    Bateman DN; Dean CR; Mucklow JC; Bulpitt CJ; Dollery CT
    Br J Clin Pharmacol; 1979 Apr; 7(4):357-63. PubMed ID: 375958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the efficacy and long-term tolerability of a combination of atenolol and nifedipine with atenolol alone in the treatment of hypertension.
    Mayhew S
    Br J Clin Pract; 1990 Jul; 44(7):280-2. PubMed ID: 2206826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of nifedipine as a step 3 antihypertensive drug.
    Murphy MB; Scriven AJ; Dollery CT
    Hypertension; 1983; 5(4 Pt 2):II118-21. PubMed ID: 6345370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regression of left ventricular hypertrophy during combined atenolol and nifedipine treatment.
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    Drugs; 1988; 35 Suppl 4():39-43. PubMed ID: 2967752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Krakoff LR; Bravo EL; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.